Menu Search
Equities

GN Store Nord A/S

GN:CPH

GN Store Nord A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)131.05
  • Today's Change0.85 / 0.65%
  • Shares traded413.84k
  • 1 Year change-12.52%
  • Beta1.1485
Data delayed at least 15 minutes, as of Nov 21 2024 16:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy5
Outperform8
Hold5
Sell2
Strong Sell0

Share price forecast in DKK

The 20 analysts offering 12 month price targets for GN Store Nord A/S have a median target of 215.00, with a high estimate of 300.00 and a low estimate of 135.00. The median estimate represents a 65.13% increase from the last price of 130.20.
High130.4%300.00
Med65.1%215.00
Low3.7%135.00

Dividends in DKK

Dividend information is not available for GN Store Nord A/S.
Div growth (TTM)--
More ▼

Earnings history & estimates in DKK

On Nov 06, 2024, GN Store Nord A/S reported 3rd quarter 2024 earnings of 1.86 per share. This result exceeded the 1.75 consensus of the 5 analysts covering the company and exceeded last year's 3rd quarter results by 27.40%.
The next earnings announcement is expected on Feb 06, 2025.
Average growth rate+165.30%
GN Store Nord A/S reported annual 2023 earnings of 1.64 per share on Feb 08, 2024.
Average growth rate-25.38%
More ▼

Revenue history & estimates in DKK

GN Store Nord A/S had 3rd quarter 2024 revenues of 4.16bn. This missed the 4.38bn consensus estimate of the 10 analysts following the company. This was 1.19% below the prior year's 3rd quarter results.
Average growth rate-0.98%
GN Store Nord A/S had revenues for the full year 2023 of 18.12bn. This was 3.03% below the prior year's results.
Average growth rate+9.92%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.